December 2025
1. FREEDMAN DO
   Asheville, North Carolina: The Origin of the American Tuberculosis Sanitarium Movement.
   Ann Intern Med. 2025 Dec 2. doi: 10.7326/ANNALS-25-02861.
   

   >> Share

   
   October 2025
2. SACKS HS
   In primary CDI, fecal microbiota transplantation was noninferior to vancomycin for clinical cure at 14 d without recurrence at 60 d.
   Ann Intern Med. 2025;178:JC117.
   

   >> Share

   
   August 2025
3. KANJEE Z, Stead W, Jassar A, Reynolds EE, et al
   How Would You Treat Tricuspid Valve Infective Endocarditis in a Patient Who Uses Injection Drugs? Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
   Ann Intern Med. 2025 Aug 12. doi: 10.7326/ANNALS-25-02049.
   

   >> Share

   
   
4. ANAEKWE A, Brennan K, Glatt AE
   In urogenital gonorrhea, gepotidacin was noninferior to ceftriaxone + azithromycin for microbiological success.
   Ann Intern Med. 2025;178:JC88.
   

   >> Share

   
   July 2025
5. JUUL FE, Bretthauer M, Johnsen PH, Samy F, et al
   Fecal Microbiota Transplantation Versus Vancomycin for Primary Clostridioides difficile Infection : A Randomized Controlled Trial.
   Ann Intern Med. 2025;178:940-947.
   

   >> Share

   
   May 2025
6. SMITH RP
   Lyme Disease.
   Ann Intern Med. 2025;178:ITC65-ITC80.
   

   >> Share

   
   April 2025
7. YEK C, Mancera AG, Diao G, Walker M, et al
   Impact of the COVID-19 Pandemic on Antibiotic Resistant Infection Burden in U.S. Hospitals : Retrospective Cohort Study of Trends and Risk Factors.
   Ann Intern Med. 2025 Apr 29. doi: 10.7326/ANNALS-24-03078.
   

   >> Share

   
   
8. HAMED HKA, Nachman A, Riopel N, Schuster M, et al
   Infectious Diseases: What You May Have Missed in 2024.
   Ann Intern Med. 2025 Apr 1. doi: 10.7326/ANNALS-25-00925.
   

   >> Share

   
   March 2025
9. RYDER JH, Kalil AC
   In hospitalized patients with BSI, antibiotic therapy for 7 d was noninferior to 14 d for 90-d mortality.
   Ann Intern Med. 2025;178:JC27.
   

   >> Share

   
   February 2025
10. LI Y, Marks SM, Beeler Asay GR, Winston CA, et al
    Effectiveness and Cost-Effectiveness of Expanded Targeted Testing and Treatment of Latent Tuberculosis Infection Among the Medicare Population in 2022.
    Ann Intern Med. 2025 Feb 7. doi: 10.7326/ANNALS-24-00870.
    

    >> Share

    
    
11. NACHMAN A, Chagla Z
    In rifampicin-resistant TB, bedaquiline-containing regimens reduced unfavorable status vs. a control regimen at 132 wk.
    Ann Intern Med. 2025;178:JC19.
    

    >> Share

    
    August 2024
12. GLATT AE
    In adult inpatients with pneumonia, CPOE-based vs. routine stewardship reduced extended-spectrum antibiotic use.
    Ann Intern Med. 2024;177:JC90.
    

    >> Share

    
    June 2024
13. HOWARD-ANDERSON J, Morgan DJ
    Moving Beyond Central Line-Associated Bloodstream Infections.
    Ann Intern Med. 2024;177:822-823.
    

    >> Share

    
    May 2024
14. OURANOS K, Mylonakis E
    In Enterobacterales bacteremia, antipseudomonal beta-lactam de-escalation was noninferior to continuation for clinical cure at 3 to 5 d.
    Ann Intern Med. 2024;177:JC52.
    

    >> Share

    
    
15. SACKS HS
    In community-acquired pneumonia, adding oral clarithromycin to standard care increased early clinical response.
    Ann Intern Med. 2024;177:JC51.
    

    >> Share

    
    
16. STRICH JR, Mishuk A, Diao G, Lawandi A, et al
    Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in U.S. Hospitals : A Retrospective Cohort Study.
    Ann Intern Med. 2024;177:559-572.
    

    >> Share

    
    April 2024
17. LI Y, Regan M, Swartwood NA, Barham T, et al
    Disparities in Tuberculosis Incidence by Race and Ethnicity Among the U.S.-Born Population in the United States, 2011 to 2021 : An Analysis of National Disease Registry Data.
    Ann Intern Med. 2024 Apr 2. doi: 10.7326/M23-2975.
    

    >> Share

    
    
18. CASTRO KG, Shah NS
    Beyond the Bacillus: Closing Gaps in Tuberculosis Health Disparities Requires Targeting Social Determinants.
    Ann Intern Med. 2024 Apr 2. doi: 10.7326/M24-0548.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share